| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |